Global Therapeutic Vaccines Market - Industry Analysis by Player, Region, Type, Application and Sales Channel, Forecast

Chapter 1 Therapeutic Vaccines Market Overview

1.1 Therapeutic Vaccines Definition

1.2 Global Therapeutic Vaccines Market Size Status and Outlook (2019-2032)

1.3 Global Therapeutic Vaccines Market Size Comparison by Region (2019-2032)

1.4 Global Therapeutic Vaccines Market Size Comparison by Type (2019-2032)

1.5 Global Therapeutic Vaccines Market Size Comparison by Application (2019-2032)

1.6 Global Therapeutic Vaccines Market Size Comparison by Sales Channel (2019-2032)

1.7 Therapeutic Vaccines Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Therapeutic Vaccines Market Snapshot

2.2 Global Therapeutic Vaccines Market Volume & Revenue 2019-2025

2.3 Global Therapeutic Vaccines Market Differential Growth Potential Analysis by Type, 2019-2032 (USD Million)

2.4 Global Therapeutic Vaccines Market Differential Growth Potential Analysis by Application, 2019-2032 (USD Million)

2.5 Global Therapeutic Vaccines Market Differential Growth Potential Analysis by Sales Channels, 2019-2032 (USD Million)

2.6 Global Therapeutic Vaccines Market Differential Growth Potential Analysis by Region, 2019-2032 (USD Million)

Chapter 3 Therapeutic Vaccines Market Segment Analysis by Player

3.1 Global Therapeutic Vaccines Sales and Market Share by Player (2023-2025)

3.2 Global Therapeutic Vaccines Revenue and Market Share by Player (2023-2025)

3.3 Global Therapeutic Vaccines Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Therapeutic Vaccines Market Segment Analysis by Type

4.1 Global Therapeutic Vaccines Market by Type

4.1.1 Peptide Therapeutic Vaccine

4.1.2 Cell Therapeutic Vaccine

4.1.3 Nucleic Acid Therapeutic Vaccine

4.2 Global Therapeutic Vaccines Sales and Market Share by Type (2019-2025)

4.3 Global Therapeutic Vaccines Revenue and Market Share by Type (2019-2025)

4.4 Global Therapeutic Vaccines Average Price by Type (2019-2025)

4.5 Leading Players of Therapeutic Vaccines by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Therapeutic Vaccines Market Segment Analysis by Application

5.1 Global Therapeutic Vaccines Market by Application

5.1.1 Oncotherapy

5.1.2 Hepatitis B

5.1.3 Tuberculosis

5.1.4 Herpes Simplex Virus

5.1.5 Others

5.2 Global Therapeutic Vaccines Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Therapeutic Vaccines by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Therapeutic Vaccines Market Segment Analysis by Sales Channel

6.1 Global Therapeutic Vaccines Market by Sales Channel

6.1.1 Global Therapeutic Vaccines Market, by Direct Channel Market Analysis 2019-2032 (USD Million)

6.1.2 Global Therapeutic Vaccines Market, by Distribution Channel Market Analysis 2019-2032 (USD Million)

6.2 Global Therapeutic Vaccines Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Therapeutic Vaccines by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Therapeutic Vaccines Market Segment Analysis by Region

7.1 Global Therapeutic Vaccines Market Size and CAGR by Region (2019-2032)

7.2 Global Therapeutic Vaccines Sales and Market Share by Region (2019-2025)

7.3 Global Therapeutic Vaccines Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Therapeutic Vaccines Market Share by Type

7.4.3 North America Therapeutic Vaccines Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Therapeutic Vaccines Market Share by Type

7.5.3 Europe Therapeutic Vaccines Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Therapeutic Vaccines Market Share by Type

7.6.3 Asia-Pacific Therapeutic Vaccines Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Therapeutic Vaccines Market Share by Type

7.7.3 South America Therapeutic Vaccines Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Therapeutic Vaccines Market Share by Type

7.8.3 Middle East & Africa Therapeutic Vaccines Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.8.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Therapeutic Vaccines Players

8.1 Northeast Biotherapeutics

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Agenus

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Vaccinogen Inc

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 CIMAB S.A

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Dendreon

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Corixa

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 AVAX Technologies

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Therapeutic Vaccines

9.1 Industrial Chain of Therapeutic Vaccines

9.2 Upstream of Therapeutic Vaccines

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Therapeutic Vaccines

9.3.1 Leading Distributors/Dealers of Therapeutic Vaccines

9.3.2 Leading Consumers of Therapeutic Vaccines

Chapter 10. Global Therapeutic Vaccines Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Therapeutic Vaccines Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Therapeutic Vaccines Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Therapeutic Vaccines (2026-2032)

11.1 Global Therapeutic Vaccines Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Therapeutic Vaccines Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Therapeutic Vaccines Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Therapeutic Vaccines Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Therapeutic Vaccines Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Therapeutic Vaccines Import-Export, 2019-2025

12.2 Europe Therapeutic Vaccines Import-Export, 2019-2025

12.3 Asia Pacific Therapeutic Vaccines Import-Export, 2019-2025

12.4 South America Therapeutic Vaccines Import-Export, 2019-2025

12.5 Middle East & Africa Therapeutic Vaccines Import-Export, 2019-2025

Chapter 13. Demand-Supply Gap Analysis (If Applicable)

13.1 North America Therapeutic Vaccines Demand-Supply, 2019-2025

13.2 Europe Therapeutic Vaccines Demand-Supply, 2019-2025

13.3 Asia Pacific Therapeutic Vaccines Demand-Supply, 2019-2025

13.4 South America Therapeutic Vaccines Demand-Supply, 2019-2025

13.5 Middle East & Africa Therapeutic Vaccines Demand-Supply, 2019-2025

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources